Previous studies have sought to dissect the molecular pathways responsible for mutant LRRK2-mediated PD utilized RNA sequencing (RNA-seq) data acquired from patient blood of idiopathic and LRRK2-G2019S carriers [48,49]. The gene discussed is LRRK2; the disease is Parkinson disease.